STOCK TITAN

Tango Therapeutics, Inc. (TNGX) Revenue by Year

TNGX

Tango Therapeutics, Inc. generated $62.4M in revenue in fiscal year 2025. This represents an increase of 48.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $53.8M in revenue. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Tango Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $62.4M
YoY +48.3%
5Y CAGR +52.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TNGX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Revenue$53.8M$62.4M+48.3%$42.1M+15.2%$36.5M+46.9%$24.9M-32.9%$37.0M+383.8%$7.7M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

TNGX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$0-100.0%$0-100.0%$0-100.0%$53.8M+363.6%$3.2M-84.0%$5.4M-16.7%$4.1M-24.2%$11.6M+8.2%$19.9M+36.1%$6.5M+12.2%$5.4M-15.3%$10.7M+55.1%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Tango Therapeutics, Inc. financials

Frequently Asked Questions

What was Tango Therapeutics, Inc.'s revenue in fiscal year 2025?

Tango Therapeutics, Inc. generated $62.4M in revenue in fiscal year 2025.

How fast is Tango Therapeutics, Inc.'s revenue growing?

Tango Therapeutics, Inc. (TNGX) revenue rose by 48.3% year over year, from $42.1M to $62.4M in fiscal year 2025.

What is Tango Therapeutics, Inc.'s revenue over the last twelve months?

Tango Therapeutics, Inc. (TNGX) reported $53.8M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 6 fiscal years this page covers, Tango Therapeutics, Inc. (TNGX) revenue went from $7.7M in fiscal year 2020 to $62.4M in fiscal year 2025.

Tango Therapeutics, Inc. (TNGX) reported $0 in revenue in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Tango Therapeutics, Inc. (TNGX) reported on that line in every period on record.